Skip to main content
. 2024 Jan 4;5:1321284. doi: 10.3389/frph.2023.1321284

Table 2.

Characteristics and other treatments of 114 pregnant patients with low serum estradiol in early pregnancy by treatment.

Treatment
No Estradiol or DHEA 2009–2011 Estradiol 2013–2015 DHEA 2015–2017
Medication dose [mg; mean (range)] 4.0 [2.0–6.0] 24.2 [10.0–50.0]
Total patients 22 52 40
Mean age 37.3 36.1 37.2
Previous live birth (%) 50.0 50.0 55.0
Conceived always miscarried (%) 40.9 28.8 37.5
Mean number of previous miscarriage 2.1 2.1 2.4
Never previously conceived (%) 13.6 21.2 10.0
Other treatments during current pregnancy (%)a
Vitamin B6 9.5 7.7 10.0
Vitamin B12 9.5 9.6 5.0
Selenium 11.5 27.5
Aspirinb 19.0 28.8 37.5
Enoxaparin 4.8 7.7 5.0
Progesterone 85.7 92.3 90.0
Levothyroxinec 14.3 19.2 40.0
Hydrocortisone 4.8 1.9 -
Metformin 9.5 9.6 5.0
Low-dose Naltrexoned 38.1 40.4 75.0
Prednisolonee 4.8 46.2 60.0
Pregnenolonef 20.0

DHEA = dehydroepiandrosterone.

a

Folic acid, Omega-3 fish oil and vitamin D3 were routinely prescribed to all patients.

b

Aspirin 75 mg given for abnormal thrombophilia screen.

c

Levothyroxine for borderline thyroid dysfunction to keep TSH levels between 1–2 iu/L.

d

Low dose Naltrexone 3–4.5 mg nightly for persistent fatigue, low mood, anxiety, PMS and dysmenorrhea.

e

Prednisolone 5 mg once per morning for PCOS, hyperandrogenemia or low DHEA.

f

Started after first 6 weeks of DHEA supplementation.